Filter
5567
Filtered Results: 5567
Text search:
drug
development
Featured
Recommendations
482
New Publications
1482
Language
Document type
No document type
3359
Studies & Reports
885
Guidelines
676
Manuals
242
Strategic & Response Plan
180
Training Material
81
Fact sheets
80
Situation Updates
20
Infographics
14
Resource Platforms
11
Brochures
8
Online Courses
7
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
314
Global
202
Kenya
176
South Africa
133
Ethiopia
131
Uganda
129
Nigeria
119
Western and Central Europe
110
Tanzania
105
Nepal
101
Sierra Leone
92
Zambia
90
Liberia
89
Malawi
85
Myanmar / Burma
80
Latin America and the Carribbean
76
Ghana
75
Africa
75
Bangladesh
72
Rwanda
66
Namibia
61
Ukraine
57
Eastern Europe
57
Philippines
52
Zimbabwe
44
Asia
44
South–East Asia Region
40
Cambodia
39
Russia
38
Lesotho
37
Indonesia
32
Botswana
29
Congo, Democratic Republic of
28
Mozambique
27
Syria
23
Eswatini/ Swaziland
23
Senegal
22
Burkina Faso
20
Colombia
19
Germany
19
Brazil
17
South Sudan
17
Cameroon
16
East and Southern Africa
16
USA
15
Haiti
15
West and Central Africa
15
Middle East and North Africa
14
Tajikistan
13
Albania
12
Venezuela
12
Thailand
11
Pakistan
11
China
10
Guinea
10
Vietnam
10
Afghanistan
9
Eastern Europe and Central Asia
9
Georgia
9
Argentina
8
Sudan
8
Armenia
7
Paraguay
7
Moldova
7
Sri Lanka
7
Mexico
6
Laos
6
Western Pacific Region
6
North America
6
Yemen
6
North Macedonia
5
El Salvador
5
Benin
5
Peru
5
Lebanon
5
Central African Republic
5
Iraq
5
Timor Leste/ East Timor
4
Iran
4
Jordan
4
Jamaica
4
United Kingdom
4
Mali
4
Bhutan
4
Somalia
4
Madagascar
4
Turkey
3
Fiji
3
Kyrgyzstan
3
Côte d’Ivoire / Ivory Coast
3
Bolivia
3
Papua New Guinea
3
Palestine
3
Honduras
3
Angola
3
Libya
3
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Estonia
2
Uzbekistan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
France
2
Portugal
2
Spain
2
Belarus
2
Southern Africa
2
Nicaragua
2
Poland
2
Chad
2
Ecuador
2
Guatemala
2
North Korea
1
Switzerland
1
Australia
1
Gambia
1
Singapore
1
Congo-Brazzaville
1
Niger
1
Mongolia
1
Qatar
1
Bulgaria
1
Dominican Republic
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Panama
1
Egypt
1
Romania
1
Greece
1
Authors & Publishers
Publication Years
Category
Countries
2172
Clinical Guidelines
473
Public Health
263
Women & Child Health
214
Key Resources
155
Capacity Building
79
Pharmacy & Technologies
64
Annual Report MEDBOX
1
Toolboxes
HIV
630
Mental Health
549
TB
529
AMR
288
NTDs
241
COVID-19
207
Pharmacy
160
NCDs
117
Caregiver
108
Rapid Response
92
Malaria
91
Ebola & Marburg
81
Planetary Health
78
Refugee
70
Disability
65
Global Health Education
61
Conflict
58
Health Financing Toolbox
53
Polio
22
Natural Hazards
21
Zika
17
Specific Hazards
16
Cholera
16
Social Ethics
14
Effectiveness of Education and an Antibiotic-Control Program in a Tertiary Care Hospital in Thailand
Overuse of antimicrobial agents occurs globally in both community and hospital settings. Misuse of antibiotics can lead to a variety of adverse outcomes, including the development of antimicrobial resistanceand increased cost of hospitalization. This issuehas been particularly problematic in de...
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections and could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Althoug...
This study addresses part of the Terms of Reference for a scoping report ‘An analysis of approaches to laboratory capacity strengthening for drug resistant infections in low and middle income countries’. It has been produced as a separate report because it is also very relevant for a second stud...
Adolescence is a critical stage in life for physical, cognitive and emotional development, shaping future health and well-being. Comprehensive measurement of adolescent health is essential to prioritize health issues, guide interventions and track progress. However, global, regional and national ado...
Summary Report on the Comprehensive Study
This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of their authors and do not necessarily reflect the views of USAID or th...
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Annex 1: Measuring progress towards targets
Annex 2: Modelling the impact of the 90-(90)-90 strategy
Annex 3: Investment packages by country setting
Annex 4: Country strategies
Annex 5: Strategic frameworks for research and development for new tools
Annex 6 : Estimating the cost of the 90-(90)-...
The World Health Organization's fourth Country Cooperation Strategy 2022-2026 is an outcome of a consultative process with inputs from the Ministry of Health, various agencies in the health sector, and other relevant stakeholders. It has been developed to provide strategic direction and support towa...
The revised guidelines contain recommendations for specific administrative, environmental controls and respiratory protection, following the assessment made by an external group of experts convened as members of the Guideline Development Group. Moreover, these guidelines focus on interventions speci...
Based on the Vulnerability Index developed in this review, an estimated 22.7 million persons in Myanmar, or 44% of the population, were found to have some form of vulnerability related to human development and/or exposure to active conflict/violence. These people experience varying combinations of p...
Purpose of these Guidelines
These guidelines are designed to help members of the public to provide first aid to someone who is at risk of suicide. The role of the first aider is to assist the person until appropriate professional help is received or the crisis resolves.
Development of these Guidel...
HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination...
The Rwandan Ministry of Health recognizes the threat that Non-Communicable Diseases (NCDs) pose to health and development in Rwanda and in 2009 articulates strategies to respond to them in the Health Sector Strategic Plan 2012 - 2018 (HSSP3). Among other things, the plan calls for a national prevale...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
Germany has become a visible actor in global health in the past 10 years. In this Series paper, we describe how this development complements a broad change in perspective in German foreign policy.
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and vaccines. Now mid-way through the scale-up phase, the tools we need to fundamentally change the course o...
This was a Phase 3, multi-center, randomized, open-label, parallel-group, active control study where 273 male and female patients with first stage Trypanosoma brucei gambiense HAT were treated at six sites: one trypanosomiasis reference center in Angola, one hospital in South Sudan, and four hospita...
